2 completed, 2 recruiting, 1 not yet recruiting, 1 terminated. 2 Phase 4, 1 Early Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Anticoagulation Bridge: new trials by email Literature Review of Anticoagulation Bridge trials Research Report on Anticoagulation Bridge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy Rivaroxaban, or Edoxaban , or Apixaban , or Dabigatran, Aspirin - Stroke, Acute Ischemic Stroke | Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 680 | 2026-08-15 | 2026-08-05 |
| Safety of Anticoagulation Therapy in Cirrhotic Patients With PVT and Severe Thrombocytopenia Anticoagulation Therapy - Thrombocytopenia Related to Chronic Liver Disease, Anticoagulation Treatment | Completed | Qilu Hospital of Shandong University | 304 | 2025-09-01 | 2026-10-21 | |
| MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis Endovascular Thrombectomy, Anticoagulation Therapy - Cerebral Venous Sinus Thrombosis | Not applicable | Recruiting | Middle East North Africa Stroke and Interventional Neurotherapies Organization | 440 | 2025-01-01 | 2026-10-21 |
| Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis Anticoagulation Therapy - Venous Thromboembolism, Cancer | Phase 4 | Recruiting | Ottawa Hospital Research Institute | 330 | 2024-12-19 | 2026-09-21 |
| Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study Anticoagulation Therapy - Atrial Fibrillation, Stroke, Ischemic | Unknown | University of Turku | 1300 | 2019-06-01 | 2024-05-08 | |
| AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS) AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems, Anticoagulation Therapy - Post-Operative Atrial Fibrillation | Phase 4 | Completed | AtriCure, Inc. | 562 | 2016-02-01 | 2021-11-24 |
| Statin Use in Patients With Acute VTE Atorvastatin, Anticoagulation Therapy - Venous Thromboembolism | Early Phase 1 | Terminated | Ohio State University | 21 | 2015-01-01 | 2020-10-19 |
Ischemic Stroke (2) · Venous Thromboembolism (2) · Atrial Fibrillation (1) · Catheter-Related Infections (1) · Liver Cirrhosis (1) · Neoplasms (1) · Stroke (1) · Thrombocytopenia (1) · Upper Extremity Deep Vein Thrombosis (1)
AtriCure, Inc. (1) · Middle East North Africa Stroke and Interventional Neurotherapies Organization (1) · Ohio State University (1) · Ottawa Hospital Research Institute (1) · Qilu Hospital of Shandong University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Turku (1)
United States (2) · Canada (1) · China (1) · Egypt (1) · Finland (1) · Jordan (1) · Morocco (1) · Pakistan (1) · Qatar (1) · Saudi Arabia (1) · Tunisia (1) · Turkey (Türkiye) (1)
Min Lou, PhD, MD (1) · Sydney Gaynor, MD (1) · Tzu-Fei Wang, MD (1) · Tzu-Fei Wang, MD, MPH (1)